Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:06 p.m.

    📋 INCYTE CORPORATION (INCY) - Financial Results

    Filing Date: 2022-08-02

    Accepted: 2022-08-02 07:25:54

    Event Type: Financial Results

    Event Details:

    Incyte Corporation (INCY) Reports Q3 2022 Financial Results Incyte Corporation (INCY) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 50636
    • Net Income: 226353
    • EPS: 1.01
    • Cash and equivalents: 2722425
      • targeting monoclonal antibody. In 2010

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Selling General Administrative 253.28K 462.86K $-209.58K -45.28%
    Costs And Expenses Selling General Administrative 168.86K 462.86K $-294.00K -63.52%
    Total Other Income Expense 4.39K 1.78K $2.61K +146.35%
    Interest Expense -358.00 -1.36K $1.00K +73.64%
    Assets Cash Equivalents Marketable Securities 2.72M 2.72M $0.00 +0.00%
    Assets Property Equipment Net 721.33K 721.33K $0.00 +0.00%
    Assets Prepaid Expenses Other Current Assets 190.61K 190.61K $0.00 +0.00%
    Revenue 705.71K 1.64M $-938.92K -57.09%
    Selling, General & Administrative 168.86K 253.28K $-84.42K -33.33%
    Interest Expense -358.00 -1.36K $1.00K +73.64%
    Cash and Marketable Securities 2.35M 2.72M $-374.23K -13.75%
    Property and Equipment, Net 723.92K 721.33K $2.59K +0.36%
    Other Assets 165.30K 190.61K $-25.30K -13.28%
    Intangible Assets, Net 150.75K 139.99K $10.77K +7.69%
    Accounts Payable 885.08K 962.78K $-77.70K -8.07%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Incyte Corporation
    • CIK: 0000879169
    • Ticker Symbol: INCY
    • Period End Date: 2022-08-02
    • Document Type: 8-K

Search

News categories